| Role |
Name |
Disclosure |
Details |
| Author | Cheryl Ann Palmer, MD, Professor, Departments of Pathology and Neurology, University of Alabama at Birmingham School of Medicine; Consulting Staff, Departments of Pathology and Neurology, University of Alabama at Birmingham Hospital; Consulting Staff, Departments of Pathology and Neurology, Veteran Affairs Medical Center; Consulting Staff, Department of Pathology, Children's Hospital of Alabama | Nothing to disclose | Details | | Coauthor | Daniel Keith Harrison, MD, Neuropathology Fellow, Department of Pathology, University of Alabama at Birmingham | Nothing to disclose | Details | | Medical Editor | Scott C Dulebohn, MD, Assistant Professor, Department of Surgery, Division of Neurosurgery, University of Minnesota College of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc | Nothing to disclose | Details | | CME Editor | Herbert H Engelhard III, MD, PhD, Director, UIC Neuro-Oncology Program, Chief, Division of Neuro-Oncology, Associate Professor, Department of Neurosurgery, University of Illinois at Chicago | Nothing to disclose | Details | | Chief Editor | Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Scott C Dulebohn, Medical Editor |
The contributor discloses no conflict of interest. |
|